Skip to main content
Jon Wang, MD, Orthopaedic Surgery, Tucson, AZ

JonBWangMD

Orthopaedic Surgery Tucson, AZ

Orthopedic Sports Medicine

Physician

Are you Dr. Wang?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 50 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    6320 N. La Cholla Blvd #200
    Tucson, AZ 85741
    Phone+1 520-382-8200
    Fax+1 520-297-3505

Summary

  • Dr. Jon Wang, MD is a board certified orthopedic surgeon in Tucson, Arizona. He is currently licensed to practice medicine in Arizona. He is affiliated with Northwest Medical Center and TMC HealthCare.

Education & Training

  • Hospital for Special Surgery/Cornell Medical Center
    Hospital for Special Surgery/Cornell Medical CenterResidency, Orthopaedic Surgery, 1974 - 1977
  • Icahn School of Medicine at Mount Sinai/Morningside/West
    Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Surgery, 1972 - 1973
  • Icahn School of Medicine at Mount Sinai/Morningside/West
    Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Surgery, 1969 - 1970
  • Icahn School of Medicine at Mount Sinai (Morningside)
    Icahn School of Medicine at Mount Sinai (Morningside)Internship, Transitional Year, 1968 - 1969
  • University of New Mexico School of Medicine
    University of New Mexico School of MedicineClass of 1968

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 1977 - 2021
  • American Board of Orthopaedic Surgery Orthopaedic Surgery

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012

Publications & Presentations

PubMed

Press Mentions

  • CStone Completes Registration Filing for the Phase I Trial of Its Tumor Immune Microenvironment Modulator CS3005 to Enable Study Initiation in Australia
    CStone Completes Registration Filing for the Phase I Trial of Its Tumor Immune Microenvironment Modulator CS3005 to Enable Study Initiation in AustraliaDecember 12th, 2019
  • CStone Pharmaceuticals Presented Poster of Pre-Clinical Result for CS1003 at AACR
    CStone Pharmaceuticals Presented Poster of Pre-Clinical Result for CS1003 at AACRApril 4th, 2019
  • CStone Received IND Approval in China for HDAC6 Inhibitor CS3003
    CStone Received IND Approval in China for HDAC6 Inhibitor CS3003March 12th, 2019
  • Join now to see all